CHU de Dijon — Dijon

Public research footprint of CHU de Dijon, compiled from the ClinicalTrials.gov public registry.

380

Registered studies

106

Active

Recruiting now

201

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed/Refractory Peripheral T-Cell Lymphoma · Marginal Zone Lymphoma · Malignant Melanoma · Sperm Preservation in Oncological Patients

Recently updated registry entries

NCT06476184 — Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly… (Recruiting)
NCT07039110 — Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants… (Recruiting)
NCT04487639 — Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Dijon?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.